blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0421392

EP0421392 - Anti-hCG-beta core monoclonal antibody, its production and use [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.06.1995
Database last updated on 19.10.2024
Most recent event   Tooltip23.12.1999Lapse of the patent in a contracting state
New state(s): GR, LU
published on 09.02.2000 [2000/06]
Applicant(s)For all designated states
Takeda Chemical Industries, Ltd.
1-1, Doshomachi 4-chome
Chuo-ku, Osaka / JP
[1992/40]
Former [1991/15]For all designated states
TAKEDA CHEMICAL INDUSTRIES, LTD.
3-6 Doshomachi 2-chome
Chuo-ku, Osaka 541 / JP
Inventor(s)01 / Kobayashi, Kiyoshi
1088 Oaza-hara, Matsumoto
Nagano 390-03 / JP
02 / Katsuno, Makoto
B202 3733-2 Satoyamabe
Matsumoto, Nagano 390-02 / JP
03 / Kobayashi, Takahisa
160 Oaza-mizukuma, Matsumoto
Nagano 390 / JP
[1991/15]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [1991/15]von Kreisler, Alek, Dipl.-Chem., et al
Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41
D-50462 Köln / DE
Application number, filing date90118991.004.10.1990
[1991/15]
Priority number, dateJP1989025929304.10.1989         Original published format: JP 25929389
[1991/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0421392
Date:10.04.1991
Language:EN
[1991/15]
Type: B1 Patent specification 
No.:EP0421392
Date:17.08.1994
Language:EN
[1994/33]
Search report(s)(Supplementary) European search report - dispatched on:EP29.11.1990
ClassificationIPC:C12N5/20, C12P21/08, G01N33/577, G01N33/76
[1991/15]
CPC:
C07K16/26 (EP,US); Y10S436/813 (EP); Y10S436/817 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/15]
TitleGerman:Monoklonaler Antikörper gegen Kern-hCG-beta, seine Herstellung und Verwendung[1991/15]
English:Anti-hCG-beta core monoclonal antibody, its production and use[1991/15]
French:Anticorps monoclonal contre le hCG-bêta à noyau, sa production et son utilisation[1991/15]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure06.07.1991Examination requested  [1991/36]
22.04.1993Despatch of a communication from the examining division (Time limit: M06)
28.09.1993Reply to a communication from the examining division
19.10.1993Despatch of communication of intention to grant (Approval: Yes)
08.02.1994Communication of intention to grant the patent
03.05.1994Fee for grant paid
03.05.1994Fee for publishing/printing paid
Opposition(s)18.05.1995No opposition filed within time limit [1995/32]
Fees paidRenewal fee
27.10.1992Renewal fee patent year 03
26.10.1993Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT17.08.1994
BE17.08.1994
GR17.08.1994
NL17.08.1994
CH31.10.1994
LI31.10.1994
LU31.10.1994
DK17.11.1994
SE17.11.1994
[2000/04]
Former [1996/16]AT17.08.1994
BE17.08.1994
NL17.08.1994
CH31.10.1994
LI31.10.1994
DK17.11.1994
SE17.11.1994
Former [1995/36]AT17.08.1994
BE17.08.1994
NL17.08.1994
CH31.10.1994
LI31.10.1994
SE17.11.1994
Former [1995/29]AT17.08.1994
BE17.08.1994
NL17.08.1994
SE17.11.1994
Former [1995/26]AT17.08.1994
BE17.08.1994
NL17.08.1994
Former [1995/15]AT17.08.1994
NL17.08.1994
Former [1995/15]AT17.08.1994
Documents cited:Search[XD]  - ENDOCRINOLOGY vol. 123, no. 1, July 1988, Baltimore, USA pages 584 - 593; A. KRICHEVSKY et al.: "Preparation and characterization of antibodies to the urinary fragment ofthe human chorionic gonadotropin beta-subunit."
 [XD]  - CANCER RESEARCH vol. 48, no. 5, March 1988, Philadelphia, USA pages 1356 - 1360; L. COLE et al.: "Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: A new marker of gynecological cancers."
 [X]  - MOL. ENDOCRINOL. vol. 2, no. 9, September 1988, Baltimore, USA pages 825 - 830; L. COLE et al.: "Origin and occurrence of human chorionic gonadotropin beta-subunit core fragment."
 [X]  - J. BIOL. CHEM. vol. 262, no. 18, June 1987, Baltimore, USA pages 8551 - 8556; J-M. BIDART et al.: "Topographic antigenic determinants recognized by monoclonal antibodies onhuman choriogonadotropin beta-subunit"
 [XP]  - CHEMICAL ABSTRACTS, vol. 113, no. 5, 30 July 1990 Columbus, Ohio, USA R. NISHIMURA et al.: "Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer." page 57; left-hand column; ref. no. 34783Z
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.